Best GLP-1 on Wellcare Formulary: What’s Covered in 2026

Affiliate disclosure: The RX Index may earn a commission from some provider links on this page. That never changes our coverage findings, our sources, or what you pay. Every Wellcare, Medicare, CMS, and FDA link on this page is a plain link, not an affiliate link.

The short answer

The best GLP-1 on Wellcare formulary isn't one drug. It's one plan.

The two 2026 Wellcare standalone Part D formularies we reviewed list five standalone GLP-1 entries across four brands: Mounjaro, Ozempic injection, Ozempic tablets, Rybelsus, and Trulicity. For those five entries, the drug does not change the listed cost-sharing rule. The plan does.

After the $615 deductible, Wellcare Value Script charges $11 for a one-month in-network retail fill. Wellcare Classic charges 25% of the negotiated price. Under the open assumptions shown below, that gap can be worth about $1,350 in one year for the same medication and the same prior authorization.

Here's the part that makes people think they misread their drug list. On Value Script, those five entries sit on Tier 6. On Classic, the exact same entries sit on Tier 3. A bigger tier number that costs a fraction as much. We'll show you exactly why in a minute — and it's the single most useful thing on this page.

Soliqua is the exception. It is an insulin-and-GLP-1 combination on Tier 3 in both formularies. It has a quantity limit but no prior authorization shown. Because it is a covered insulin product, the deductible does not apply and a one-month supply costs the lesser of 25% or $35. Do not put Soliqua in the $11-versus-25% bucket.

One more thing up front: if you want a GLP-1 for weight management alone, the answer isn't on the Wellcare formulary at all. It may be the separate Medicare GLP-1 Bridge, and Wellcare cannot process that request for you. More on that below.

This makes Value Script the lower-cost Wellcare option for these five standalone formulary entries under the verified drug-cost rules. It does not prove Value Script is the best total Part D plan for every person. Premiums, every other drug you take, the pharmacy network, and Extra Help can change the full-plan answer.

Is this page for you?

Yes, if:

• Your card says Wellcare and you have Medicare drug coverage
• Your doctor mentioned Ozempic, Mounjaro, Rybelsus, Trulicity, or Soliqua
• You saw "PA," "QL," or "Tier 6" next to a drug and want to know what it means
• You're comparing Wellcare plans during open enrollment

No, if:

• You want to know which GLP-1 works best medically. A drug list can't answer that. Your prescriber can.
• Your Wellcare card is Medicaid, not Medicare. None of the Medicare cost rules below apply to you. Skip to the Medicaid section.
• You only need Medicare GLP-1 Bridge application steps. We have a page for that.

### What we actually verified On August 22, 2026, we opened these current documents ourselves:

• Wellcare Value Script (PDP) formulary, HPMS file ID 26195, edition dated 08/01/2026
• Wellcare Classic (PDP) formulary, HPMS file ID 26191, edition dated 08/01/2026
• 2026 Evidence of Coverage documents for both plan designs in California and New York, contract S4802
• The current Value Script and Classic GLP-1 prior authorization criteria
• Wellcare's 2026 formulary-change and covered-alternative documents
• Wellcare's July 9, 2026 provider bulletin on the Medicare GLP-1 Bridge
• Medicare.gov and CMS Bridge rules, including the eligibility and pharmacy-first process
• Current FDA prescribing information and compounding guidance for the claims used on this page
• Current published pricing pages for Sesame and Ro

One cross-state check nobody should skip: California and New York had different plan premiums, but the Value Script EOCs we opened both showed the same $11 Tier 6 rule, and the Classic EOCs both showed 25% Tier 3 coinsurance. We still tell you to verify your exact plan because premiums, other tiers, pharmacies, and plan IDs can differ. What we did not do: we did not enroll in a plan, submit a real prior authorization, look at anyone's member account, test a pharmacy claim, or review every Wellcare Medicare Advantage, D-SNP, or Medicaid plan. Your exact price depends on your exact plan, pharmacy, deductible balance, fill size, approval, and Extra Help status.

What is the best GLP-1 on Wellcare formulary in 2026?

For Mounjaro, Ozempic injection, Ozempic tablets, Rybelsus, and Trulicity, no single entry is cheaper within the same Wellcare plan. All five share the same plan tier and prior authorization rule, with product-specific quantity limits. Value Script has the lower listed cost sharing: $11 per one-month retail fill after the deductible, compared with 25% coinsurance on Classic.

That's an unusual answer for a "best of" page, so let us be direct about why it's the honest one.

Most pages that promise the "best GLP-1" quietly answer a different question — which one causes the most weight loss. That's a medical question. It depends on your diagnosis, your other medications, your history, and your doctor's judgment. A drug list can't touch it, and neither can we.

What a drug list can answer is: which drugs will this plan pay for, under what rules, and for how much? That question has a real answer. Here it is.

The 2026 Wellcare GLP-1 coverage map

Read the fourth row twice. It's where most people get stuck, and it's the reason this page exists.

What "a Part D-covered use" actually means

Medicare Part D is barred by law from paying for a drug used only to lose weight. That's not a Wellcare decision and it's not your pharmacist being difficult. It's the federal benefit rule.

But a GLP-1 can be covered when it is prescribed for an FDA-approved use that Part D is allowed to pay for. The main lanes that decide this page are:

1. Type 2 diabetes — the lane for Mounjaro, Ozempic, Ozempic tablets, Rybelsus, Trulicity, and Soliqua
2. Reducing major cardiovascular risk in adults with established cardiovascular disease and overweight or obesity — a Wegovy lane
3. Moderate-to-severe obstructive sleep apnea in adults with obesity — a Zepbound lane
4. Noncirrhotic MASH with moderate-to-advanced liver fibrosis — a Wegovy injection lane

The exact FDA-approved use for the exact drug belongs in the coverage request. A diagnosis that supports one drug does not automatically support another.

Which lane your prescription walks through decides everything else on this page.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path, and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized treatment-path shortlist with source-verified pricing before you choose.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

→ Check which Wellcare treatment path applies to you — free, about 60 seconds, no signup, no member ID required.

Which GLP-1 drugs are on Wellcare's 2026 drug list?

Both 2026 Wellcare standalone Part D formularies we reviewed list five standalone GLP-1 entries across four brands — Mounjaro, Ozempic injection, Ozempic tablets, Rybelsus, and Trulicity — with prior authorization and a quantity limit. Both formularies also list Soliqua, an insulin-and-GLP-1 combination, on Tier 3 with a quantity limit and no prior authorization shown. Xultophy and Bydureon BCise were removed for 2026.

Here's the full list, drug by drug.

PA = prior authorization. QL = quantity limit. The Value Script and Classic rows above come from formularies 26195 and 26191, both dated 08/01/2026. Being listed does not guarantee approval or a specific member price.

The quantity limit that trips people up

Look at Ozempic: 3 mL per 28 days.

That sounds tiny next to Mounjaro's 2 mL until you know how the pens work. An Ozempic pen holds 3 mL and delivers multiple doses. So 3 mL per 28 days means one pen per 28 days under the listed limit, not four Ozempic pens.

Mounjaro and Trulicity come in 0.5 mL single-dose pens. Four pens total 2 mL. Also one normal 28-day fill.

So the injection limits reach a similar practical result in different units. If someone tells you Wellcare allows "four pens" of Ozempic because it allows four Mounjaro pens, they're reading the wrong row.

The one GLP-1 combination on Wellcare's list that skips prior authorization

Every standalone GLP-1 entry in the table above needs prior authorization. Soliqua does not show a PA requirement in either formulary we reviewed. It shows Tier 3 and a quantity limit of 15 mL per 25 days.

And there is a second difference that matters even more: Soliqua contains insulin. The Evidence of Coverage documents we checked say a covered Tier 3 insulin product has no deductible and costs the lesser of 25% or $35 for a one-month supply. That rule applies on both Value Script and Classic.

Wellcare also dropped Xultophy, the other insulin-plus-GLP-1 combination in this comparison, for 2026 and names Soliqua as the formulary alternative.

For a Wellcare member who's already taking insulin for type 2 diabetes, that's worth knowing. There is one product on this list your prescriber may not have to win a prior authorization for first, and its insulin cost rule is separate from the $11 Tier 6 rule.

Be honest with yourself about the tradeoffs, though. Soliqua contains insulin. It's a daily injection, not weekly. It is not a swap for a standalone GLP-1, and it isn't right for everyone. This is a fact to bring to your prescriber, not a shortcut to ask for by name.

Oral or injection — what the formulary can and can't tell you

A lot of people land here because needles are the dealbreaker. Fair enough. Here's what the drug list actually settles:

One caution worth stating plainly: Ozempic tablets and Rybelsus are not interchangeable milligram for milligram. They are both semaglutide tablets, but they have different strengths and labeled dosing. FDA labeling provides a specific prescriber-directed way to switch between them after the initiation phase. Do not swap them or convert the dose on your own.

Why we won't rank these drugs by effectiveness

We could put a weight-loss percentage table here. Plenty of pages do. We're not going to, and here's the reason.

Those numbers come from separate trials with different patients, different lengths, and different measurements. Lining them up in one column looks authoritative and isn't. More to the point: your plan uses the same cost-sharing rule for the five standalone entries. So even if one drug looked better on paper, the formulary gives you no financial reason to push for it — and every medical reason to let your prescriber choose.

The coverage question and the medical question are separate. This page owns the first one.

Why Tier 6 costs less than Tier 3 on Wellcare

On Wellcare Value Script, Mounjaro, Ozempic, Ozempic tablets, Rybelsus, and Trulicity sit on Tier 6, which carries an $11 copay at an in-network retail pharmacy after the $615 deductible. On Wellcare Classic, the same five entries sit on Tier 3, which carries 25% coinsurance after the same deductible. Tier numbers are set by each plan and cannot be compared across plans — in this case the higher number is far cheaper.

This is the finding that pays for the whole page, so let's slow down.

Tier numbers are not a ranking

Most people assume tiers work like hotel stars — higher number, worse deal. That's not how Part D works. Each plan builds its own tier list and decides what each tier costs.

Wellcare Value Script has six tiers. Tier 6 is called "Select Care Drugs" — Wellcare's description is drugs commonly used to treat specific chronic conditions. It carries a flat $11 copay, at both preferred and standard in-network retail pharmacies.

Wellcare Classic has five tiers. There is no Tier 6 to put anything on. So the same standalone GLP-1 entries land on Tier 3 — Preferred Brand — at 25% coinsurance.

Same medication. Same manufacturer. Same prior authorization. Two very different bills.

Here is the Value Script tier grid from the 2026 Evidence of Coverage:

Soliqua sits outside this comparison. It is Tier 3 in both plans, but its covered-insulin rule removes the deductible and caps a one-month member share at the lesser of 25% or $35.

What this costs over a full year

Now let's turn those rules into a year.

Assumptions, stated openly: one covered standalone GLP-1 with a negotiated price around $1,000 a month, one 28- or 30-day fill each month, an in-network retail pharmacy, no Extra Help, no other drugs counting toward the deductible or cap, and a January start. Premiums are not included. Change any of those and the numbers move.

The Value Script versus Classic gap is about $1,350 under this model — for the exact same standalone medication, with the exact same paperwork.

Two honest caveats. Classic members who reach the $2,100 Part D out-of-pocket cap pay $0 for covered Part D drugs for the rest of the year. A lower negotiated price or a late-year start may keep a Classic member below the cap. And a Value Script member could still reach the cap because of other covered drugs, even though this GLP-1's $11 refills would not do it alone.

Why your first fill may still be a shock

The $11 is real. It just usually isn't the first number you see.

Before you meet the $615 deductible, you pay the plan's negotiated price until the deductible is met. A claim that crosses the deductible can also include the cost sharing that applies after it. On a brand-name GLP-1, that first trip to the pharmacy can be several hundred dollars even on Value Script. People see it, assume the $11 was marketing, and give up.

Don't. On a roughly $1,000-a-month drug, the deductible should clear on the first fill. Then the $11 rule takes over for later Value Script fills that year.

If you're starting a GLP-1 in November or December, the timing can hurt. You may face the remaining 2026 deductible and then a new plan-year deductible after January 1, 2027. If you have any medical flexibility on timing, that's worth a conversation with your prescriber. Do not delay medically needed treatment just to move a deductible.

Two smaller things that move your number

• One-month mail order is not covered under these tables. The EOCs we checked say a mail-order prescription of 34 days or less is not covered. Longer mail-order supplies have separate cost sharing. Check before you move a GLP-1 from retail.
• Extra Help changes everything. If you get the low-income subsidy, do not apply the $11 or 25% examples without checking your LIS rider or calling the number on your card.

Does this sound like your situation? → Use the Wellcare cost-and-coverage self-check — free, no member ID, nothing stored.

What does Wellcare require for GLP-1 prior authorization?

Wellcare's current GLP-1 prior authorization criteria name Mounjaro, Ozempic, Rybelsus, and Trulicity, require the diagnosis, allow all FDA-approved indications, grant approval for one year, and do not require a prerequisite drug. The formularies also mark Ozempic tablets PA. Approval is not automatic — the diagnosis and requested use still have to fit the drug's label and the plan's rules.

"PA" is the two letters that make people give up. It shouldn't.

What the letters mean

• PA — prior authorization. Your prescriber has to get Wellcare's OK before the pharmacy can fill it as covered. Without it, the claim rejects.
• QL — quantity limit. Wellcare caps how much it will pay for in a set window. See the table above.
• ST — step therapy. You would have to try a different drug first.

Notice what's missing. Wellcare's current GLP-1 criteria don't list a prerequisite drug — there's no "try metformin first, then come back" gate written into this class. That's genuinely good news, and it is easy to miss.

But hold that lightly. "No prerequisite therapy" is not "automatic yes." The diagnosis still has to be documented, and the use still has to be FDA-approved for the requested drug.

What your prescriber needs to send

Wellcare's published GLP-1 criteria expressly list the diagnosis as the required medical information. They do not publish a universal three-part rule that every request must include an A1C, a lab packet, and a full treatment history.

A clean request should still identify:

1. The exact drug, form, strength, and quantity
2. The diagnosis and FDA-approved reason for that exact drug
3. Any records Wellcare asks for after reviewing the request

Recent labs or treatment history may help when they support the diagnosis or answer a plan question. They are not listed as mandatory for every GLP-1 request in the current class criteria.

How long Wellcare has to answer

From Wellcare's own documents: a standard coverage decision generally comes within 72 hours after Wellcare receives your prescriber's supporting statement. An accepted expedited request generally comes within 24 hours.

Two things hide inside that sentence. The clock starts when the supporting statement arrives, not when your doctor first thinks about it. And "expedited" has to be requested and accepted — it isn't the default.

The 90-day cushion most people never hear about

If you're new to a Wellcare plan, or continuing on a drug that is not on the list or now has a restriction, the formulary describes a temporary 30-day supply in certain cases during your first 90 days as a member.

That is breathing room to sort out coverage. It is not proof that future fills will be paid. Use the time; don't relax into it.

Say this to your doctor's office

"My plan is Wellcare [Value Script / Classic]. The current drug list shows [drug] needs prior authorization. Could you send the exact drug, form, dose, quantity, and the FDA-approved diagnosis with the request? Please attach any records Wellcare asks for. And can you confirm whether this request belongs with Wellcare Part D or the Medicare GLP-1 Bridge?"

That last question can save days. Sending a Bridge request to Wellcare, or a normal Part D request to the Bridge processor, is an avoidable way for a prescription to stall.

Printable one-page prescriber checklist

• Exact plan name: Wellcare Value Script or Wellcare Classic
• Contract and plan number from the member card
• Exact medication, form, strength, directions, and quantity
• Diagnosis and the FDA-approved indication for that exact product
• PA route: Wellcare Part D or Medicare GLP-1 Bridge
• Any plan-requested records attached
• Standard or expedited decision requested
• Office contact and fax information confirmed
• Pharmacy name and phone number confirmed
• Written denial reason requested if the answer is no

→ Print this prescriber checklist — no email required.

Does Wellcare cover Wegovy, Zepbound, or Foundayo?

Wegovy, Zepbound, and Foundayo were not found in the two Wellcare standalone Part D formularies we reviewed on August 22, 2026. For weight management alone, those products may be available through the separate Medicare GLP-1 Bridge at $50 per covered monthly fill. For a different Part D-covered use, such as Wegovy for cardiovascular risk or MASH or Zepbound for sleep apnea, the prescriber should request a coverage determination from the member's exact Part D plan.

This is the section that changes the most outcomes, so read it carefully even if you came here for Ozempic.

What the Medicare GLP-1 Bridge is

It's a temporary federal program running July 1, 2026 through December 31, 2027. Eligible people with Medicare drug coverage can get certain GLP-1s for weight management at $50 per covered monthly fill.

The drugs on it are:

• Foundayo tablets
• Wegovy tablets
• Wegovy injection
• Zepbound KwikPen only — not the single-dose vials or single-dose pens

Ozempic and Mounjaro are not Bridge drugs.

Who qualifies for the Medicare GLP-1 Bridge?

You must be at least 18, have an eligible Medicare drug plan, use the drug for weight reduction or weight maintenance with ongoing nutrition and physical-activity changes, and meet one of these clinical gates when GLP-1 therapy starts:

• BMI 35 or higher, or
• BMI 30 or higher plus heart failure with preserved ejection fraction, uncontrolled high blood pressure despite two blood-pressure medicines, or chronic kidney disease stage 3a or higher, or
• BMI 27 or higher plus prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease

You are not eligible for the Bridge when the prescription belongs in Part D for type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH with F2–F3 fibrosis. A prescription meant to reduce major cardiovascular events should also go to the Part D plan, even when weight reduction is another goal.

If a GLP-1 is already being covered through Part D for you, keep that prescription in Part D.

How the Bridge request actually starts

The order matters:

1. Your prescriber sends the prescription for an eligible Bridge drug to your pharmacy.
2. The pharmacy sends the claim to the Medicare GLP-1 Bridge processor.
3. The prescriber waits for the pharmacy's prior authorization request.
4. The prescriber completes the Bridge prior authorization electronically or by fax.
5. The Bridge sends its decision within 72 hours after submission.

Do not submit the Bridge PA before the pharmacy claim. CMS says that can return a "patient not found" error. A Part D denial is not required before the pharmacy routes an eligible claim to the Bridge.

The pharmacy usually sends the PA request to the prescriber within 24 to 72 hours. If the office has not received it after 72 hours, it can use the CMS fax form. Prescribers can call the Medicare GLP-1 Bridge Call Center at 855-273-0102, Monday through Friday, 8 a.m. to 7 p.m. Eastern.

Three rules people trip over

One — Wellcare cannot process it. Wellcare's July 9, 2026 provider bulletin says its Part D plans cannot accept, process, or support Bridge prior authorizations, claim submissions, or reimbursements. If you call Wellcare and ask it to approve a Bridge request, the honest answer is that it can't. That's not a door closing. It's the wrong door.

Two — the Bridge is not a Wellcare benefit. It runs outside the normal Part D payment flow through Medicare's central processor. A Wellcare representative not handling it does not prove you qualify or do not qualify.

Three — having more diagnoses can lock you out. If you have type 2 diabetes, moderate-to-severe sleep apnea, or qualifying MASH, CMS says that prescription belongs in Part D, not the Bridge — even if you otherwise meet the Bridge's BMI criteria.

The side-by-side cost comparison

Sit with that cost row for a second. For GLP-1 access specifically, a Wellcare member with a Part D-covered diagnosis can pay more than a Bridge member because that diagnosis routes the prescription out of the $50 program. That is possible under these rules, not guaranteed for every member.

This table exists so you can plan, not so anyone changes a diagnosis to chase a price. Your prescriber has to submit the medically accurate reason. That isn't negotiable, and any page telling you otherwise is handing you a problem, not a solution.

Want the Bridge details? We keep them on their own pages so this one stays focused:

• Medicare GLP-1 Bridge: how the application works
• Does Wellcare cover Wegovy?
• Medicare GLP-1 Bridge tracker

"Not on the list" isn't always the end

One more thing before you move on. We searched two formularies. Wellcare publishes other formularies by plan and state, and it updates files during the year.

More importantly: when a GLP-1 is being prescribed for a use Part D can cover, a non-formulary result can still leave a real next step. Ask for a coverage determination and find out whether the plan will treat it as a formulary exception, prior authorization, or both. We'll cover that below.

Which GLP-1s did Wellcare drop for 2026?

Two GLP-1-containing products left the Wellcare 2026 formularies for different reasons. Wellcare marks Bydureon BCise discontinued and names Mounjaro, Ozempic, Rybelsus, and Trulicity as alternatives. Wellcare removed Xultophy and names Soliqua as the formulary alternative. A coverage determination can address a plan removal; it cannot make an unavailable product appear at the pharmacy.

Short section. High value. The reason for the removal changes the next move.

If you were on Xultophy and someone told you it was "just gone," they gave you half the story. A formulary exception exists precisely for plan removals. It is not automatic, but it is a real path.

What to do if Wellcare says no

The right fix depends entirely on which "no" you got. A missing prior authorization, a denied prior authorization, a quantity limit, a non-formulary drug, and a Bridge claim sent to the wrong processor can look identical at the pharmacy counter and require completely different responses. Get the exact reason in writing before you do anything.

Never accept "insurance denied it" as the whole answer. Ask what the actual message said.

The denial decoder

How a formulary exception works

If the drug isn't on your list and you need it, this is the path.

1. Ask Wellcare for a coverage determination.
2. Ask whether it is treating the request as a prior authorization, a formulary exception, or both.
3. Your prescriber sends a supporting statement explaining why the covered alternatives would not work as well for you or could cause harm.
4. Wellcare generally decides within 72 hours after receiving the supporting statement — or within 24 hours for an accepted expedited request.
5. If Wellcare says no, the denial notice must explain the appeal path.

One limit to know before you start. Drugs on Wellcare's specialty tier, Tier 5, are not eligible for a tiering exception. You cannot ask to move a Tier 5 drug to a cheaper tier. A formulary or restriction exception may still be available.

Say this on the phone

"I'm calling about [drug] prescribed for [diagnosis]. Can you confirm three things? One, is it on my exact plan's current drug list? Two, which restrictions apply? Three, is my next step a prior authorization, a coverage determination, or a formulary exception?"

Naming all three options tells the rep you already know the difference. It moves the call past the script.

→ Find the fix that matches your denial reason — our free Medicare Part D exception guide, including template language.

What if you have Wellcare Medicare Advantage, a D-SNP, or Medicaid?

The tier and cost findings on this page come from Wellcare standalone Part D formularies and do not automatically apply to Wellcare Medicare Advantage, Special Needs Plans, or Medicaid. Those formularies vary by plan and state, so you need to identify your exact plan before acting on anything here.

We'd rather tell you to stop reading than let you act on the wrong table.

Find your exact plan in 60 seconds

Look at your member card. You want to see one of these:

• PDP — a standalone drug plan. Value Script and Classic live here. This page's PDP tables may apply after you confirm the exact plan.
• HMO or PPO — a Medicare Advantage plan with drug coverage. Different formulary. Look yours up.
• D-SNP — a plan for people with both Medicare and Medicaid. Different formulary again.
• Medicaid — a state program. None of the Medicare PDP cost rules on this page apply.

Also on the card: a contract number and a plan number. That's what identifies your exact drug list and Evidence of Coverage.

If your card says Medicaid

Stop here and start over with your state.

Wellcare-branded Medicaid coverage exists in some states, and GLP-1 coverage is decided state by state through each state's preferred drug list and managed-care rules. What Kentucky covers tells you nothing about Georgia.

We're deliberately not publishing a national count of "states that cover it." Those numbers go stale, and they hide the details that decide your case — fee-for-service versus managed care, effective dates, covered uses, and the paperwork each state wants. Open your state's current list. That's the only answer that's yours.

If you're not sure

Don't guess, and don't let a website guess for you. Call the number on the back of your card and ask: "What is my exact plan name and type?" That makes everything after it correct.

If none of the covered paths work for you

Work the covered paths first. Under the verified prices on this page, they can be far cheaper, and we earn nothing on any of them. If a coverage determination, a formulary exception, and the Bridge have all been ruled out, a cash-pay treatment path exists. It sits outside Wellcare, does not count toward your Part D deductible or cap, and may add a service fee to the medication price.

Let's be straight about the order of operations, including where we make money and where we don't.

1. Wellcare Part D coverage for a covered use — we earn nothing
2. The $50 Medicare GLP-1 Bridge, if you qualify — we earn nothing
3. Manufacturer and direct cash routes — we earn nothing
4. Cash-pay telehealth — this is the only lane here where we may earn, and we're telling you before you read it

If you haven't tried a coverage determination yet, stop and do that first. It's free. On Value Script it can be the difference between $11 a month after the deductible and a cash price outside the plan.

If you qualify for the Bridge but can't find a clinician who'll handle it

This is a real and specific problem. The Bridge started July 1, 2026. Some offices may not have a working process yet, and some may not take it on.

Sesame lists a Medicare-specific weight-management service built around the Bridge. Its page says the provider handles the prescription paperwork.

Here's the flaw, stated plainly — and it's the one thing we'd change about this option:

Sesame does not bill Wellcare or Medicare for the membership. Its lowest published rate is $59 a month with annual billing, and that is on top of the $50 Bridge medication copay paid at the pharmacy. If your own prescriber will handle the Bridge, starting there avoids a separate Sesame membership fee — use the prescriber checklist above. But if your office will not handle the Bridge, Sesame offers access to a clinician through a service that already publishes a Bridge workflow.

For someone whose own office will do it, that extra fee may not be worth it. For someone whose office will not, the trade can make sense. Be honest about which one you are.

→ See Sesame's current Medicare visit availability and full monthly cost (sponsored affiliate link, opens in a new tab)

Sesame's lowest published membership rate is $59/month with annual billing and is separate from the $50 Bridge medication copay. Eligibility, prescribing, and Bridge approval are not guaranteed. Verify current pricing before paying.

If you've decided to pay cash regardless

Different reader, different answer.

Ro carries FDA-approved GLP-1 options. Ro Body membership is $39 for the first month, then $74/month with a 12-month plan prepaid annually, $89/month with a 6-month prepay, $99/month with a 3-month prepay, or $149/month if billed monthly. Medication is billed separately.

One boundary we're not going to blur: this page places Ro only in the cash-pay lane. Ro says people with Medicare or other government insurance may still be eligible for certain cash-pay options, but Ro is not Wellcare and it is not the Medicare GLP-1 Bridge processor. If what you need is someone to work a Wellcare benefit or route a Bridge claim, go back to the plan and Bridge steps above, call 1-800-MEDICARE, or contact your State Health Insurance Assistance Program, which offers free Medicare counseling.

Where Ro fits: you've established you're paying cash, and you want an online clinical review with FDA-approved medication at published prices.

→ See Ro's current eligibility and cash pricing for FDA-approved GLP-1s (sponsored affiliate link, opens in a new tab)

Eligibility is determined after clinical review. Membership and medication are billed separately. This is cash pay, not a way to bill Wellcare or the Bridge.

One thing we won't recommend here

Compounded semaglutide is not FDA-approved Wegovy or Ozempic. FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. A compounded product is not part of the Medicare GLP-1 Bridge and is not a way to use a Wellcare benefit.

A Medicare denial doesn't make a compounded product appropriate for you. Compounded drugs can serve a medical need in some cases, but that is a conversation with a licensed clinician who knows your history — not an insurance workaround. There are no compounded-provider links on this page, and that's deliberate.

Wellcare GLP-1 Coverage Checker

Five questions. About 60 seconds. No member ID, no date of birth, no form submission, nothing stored.

Question 1: What does your card say?

• Wellcare Value Script or Wellcare Classic PDP: continue to Question 2.
• HMO, PPO, Medicare Advantage, D-SNP, or Medicaid: stop. Use your exact plan's current formulary. The PDP tables above are not yours.

Question 2: Why is the medication being prescribed?

• Type 2 diabetes or another FDA-approved Part D use for the exact drug: go to Wellcare Part D.
• Weight management alone: go to Question 3.
• Wegovy for cardiovascular-risk reduction or MASH, or Zepbound for moderate-to-severe sleep apnea: ask your prescriber for a coverage determination from your exact Part D plan.

Question 3: Do you meet a Bridge clinical gate?

A Bridge gate is BMI 35 or higher; BMI 30 or higher plus one of the listed heart-failure, blood-pressure, or kidney conditions; or BMI 27 or higher plus prediabetes, a prior heart attack, prior stroke, or symptomatic peripheral artery disease.

• Yes, and the drug is for weight management: the Bridge may be your lane. Your prescriber sends the prescription to the pharmacy first.
• No or not sure: use Medicare's eligibility tool or ask your prescriber. Do not guess.

Question 4: Which covered form fits your preference?

• Tablet under Wellcare Part D: Ozempic tablets or Rybelsus, if medically appropriate and approved.
• Injection under Wellcare Part D: Mounjaro, Ozempic, or Trulicity, if medically appropriate and approved.
• Insulin-and-GLP-1 combination: Soliqua is the QL-only option in the formularies reviewed, with a separate insulin cost rule.
• Bridge: Foundayo tablets, Wegovy tablets or injection, or Zepbound KwikPen, if eligible and approved.

Question 5: Which price rule applies?

Your result sheet

Before the prescription moves, write down these six answers:

1. Exact plan name and plan type
2. Exact drug and form
3. Exact diagnosis or weight-management lane
4. PA processor: Wellcare or Medicare GLP-1 Bridge
5. Deductible status and Extra Help status
6. Exact pharmacy and requested quantity

That is enough to tell your prescriber's office where the request goes and enough to ask the pharmacy for a meaningful benefit quote.

"Is it too good to be true?"

We went looking for real people asking about this, because we wanted to be sure we were solving the right problem.

In a Medicare discussion thread about Wellcare and Mounjaro, one member described finding the drug on the plan's list and not believing what they were reading:

"Wellcare has it in their formulary as Tier 6 with prior authorization." — a member posting in r/medicare, Wellcare and Mounjaro

The member then asked whether it was too good to be true. That reaction is the whole reason this page exists. A member sees a high tier number next to a very low copay, assumes it's a mistake, and hesitates.

It isn't a mistake. Wellcare Value Script really does place Mounjaro and the other four standalone entries shown above on Tier 6 at $11 after the deductible. It looks strange only because tier numbers don't mean what most people assume.

We're sharing this as an example of how members describe the confusion — not as proof of coverage, a promise of approval, or a medical result. Your plan and your claim decide your outcome.

What we checked, and what we didn't

We built this page by opening Wellcare's own 2026 documents rather than summarizing other coverage articles. That included both standalone Part D formularies, Evidence of Coverage documents in two states, both GLP-1 prior authorization files, Wellcare's formulary-change and Bridge bulletins, CMS's Bridge workflow, and current FDA materials.

Provider-stated versus independently verified

What we did not do: we did not enroll in a plan, submit a real prior authorization, access anyone's member account, test a pharmacy claim, or review every Wellcare plan in the country. We did not make a medical judgment about any drug for any person.

Who made this and why: The RX Index Editorial Team. We pull the primary documents ourselves and put them side by side. We built this one because the tier number, the insulin exception, and the separate Bridge processor are easy to collapse into one wrong answer.

Frequently asked questions

These answers cover the plan-specific follow-ups most likely to send a Wellcare member back to search. Coverage details can change during the year, so verify against your exact plan's current drug list before acting.

What GLP-1 drugs does Wellcare cover in 2026?

In the two standalone Part D formularies we reviewed: Mounjaro, Ozempic injection, Ozempic tablets, Rybelsus, and Trulicity, each with prior authorization and a quantity limit. Both formularies also list Soliqua, an insulin-and-GLP-1 combination, on Tier 3 with a quantity limit and no PA shown.

Is Mounjaro really Tier 6 on Wellcare?

On Wellcare Value Script, yes — Tier 6 with prior authorization and a quantity limit. On Wellcare Classic, the same drug is Tier 3. Tier numbers are set by each plan, so the plan name changes the answer.

Is Tier 6 worse than Tier 3 on Wellcare?

No. In this comparison, Tier 6 is much cheaper. Value Script's Tier 6 is a flat $11 copay after the deductible. Classic's Tier 3 is 25% coinsurance after the same deductible.

Does Wellcare cover Ozempic?

Ozempic appears on both formularies we reviewed, in tablet and injection forms, with prior authorization and a quantity limit. Being listed is not the same as being approved — the prescriber still has to document a covered use.

Does Wellcare cover Ozempic for weight loss?

Not through Part D when it is used only for weight loss. Ozempic is not one of the Medicare GLP-1 Bridge drugs. A prescriber should choose an FDA-approved product and route that fits the real diagnosis and program rules.

Does Wellcare cover Wegovy?

Wegovy was not found in the two PDP formularies we reviewed. For weight management alone, Wegovy is a Medicare GLP-1 Bridge drug at $50 per covered monthly fill if you qualify. For its cardiovascular-risk or MASH indication, ask your prescriber to request a coverage determination from your exact Part D plan.

Does Wellcare cover Zepbound?

Zepbound was not found in the two PDP formularies we reviewed. Zepbound KwikPen is a Bridge drug for eligible weight-management use; the single-dose vials and single-dose pens are not. For moderate-to-severe sleep apnea in an adult with obesity, the prescription belongs in the normal Part D coverage-determination path.

How much does Soliqua cost with Wellcare?

In both reviewed PDP formularies, Soliqua is Tier 3 with a quantity limit and no PA shown. The EOCs we checked say a covered Tier 3 insulin product has no deductible and costs the lesser of 25% or $35 for a one-month supply. Your pharmacy claim is still the final member-specific quote.

How much does Ozempic cost with Wellcare?

There's no single first-fill price. On Value Script, the verified rule is the $615 deductible and then $11 per one-month in-network retail fill. On Classic, it is the deductible and then 25% until the $2,100 Part D out-of-pocket cap is reached. Extra Help and other covered drugs can change the result.

Why was my first fill so much more than $11?

You were likely still in the deductible stage. The $11 copay applies after the $615 deductible is met. A high-cost claim may clear the deductible on the first fill, but that first claim can still be several hundred dollars.

Does Wellcare require prior authorization for GLP-1 drugs?

Yes for Mounjaro, Ozempic, Rybelsus, and Trulicity in the criteria we reviewed. The formularies also mark Ozempic tablets PA. Soliqua appears with a quantity limit and no PA shown.

Do I have to try another drug first?

Wellcare's current GLP-1 prior authorization criteria do not list prerequisite therapy for this class. That's not the same as automatic approval — the diagnosis and FDA-approved use still have to fit.

What records does Wellcare require for GLP-1 prior authorization?

The current class criteria expressly list the diagnosis as required medical information. They do not publish a universal requirement for an A1C, lab packet, or full treatment history with every request. The plan can still ask for records that support the diagnosis or answer a coverage question.

How long does a Wellcare prior authorization take?

Generally 72 hours after Wellcare receives the prescriber's supporting statement, or 24 hours for an accepted expedited request. The clock starts when the supporting statement arrives.

Who qualifies for the Medicare GLP-1 Bridge?

An adult with an eligible Medicare drug plan must use the drug for weight management with ongoing lifestyle changes and meet one of CMS's BMI-and-condition gates. Type 2 diabetes, moderate-to-severe sleep apnea, and qualifying MASH route the prescription to Part D instead.

Do I need a Wellcare denial before using the Bridge?

No. CMS says a Part D denial is not required. The prescriber sends the prescription to the pharmacy, the pharmacy routes the claim to the Bridge, and the prescriber responds to the Bridge prior authorization request.

Can I appeal a Medicare GLP-1 Bridge denial?

The Bridge has no formal appeal process. CMS says the prescriber may resubmit the prior authorization when information was entered incorrectly or when updated or additional information is available.

Why did Wellcare stop covering Xultophy?

Wellcare removed it from the 2026 formulary and names Soliqua as the alternative. Because this is a plan removal, a coverage determination or formulary exception is a legitimate option if Xultophy is medically necessary.

What happened to Bydureon BCise?

Wellcare marks it discontinued and names Mounjaro, Ozempic, Rybelsus, and Trulicity as alternatives. An exception cannot make an unavailable product available, so ask the prescriber which available option fits.

Does Extra Help change my cost?

It can change Part D deductibles and cost sharing significantly. Use your LIS rider or call the number on your card instead of applying the standard $11 or 25% examples. Extra Help does not lower the separate $50 Bridge copay.

Can I get a 90-day supply?

Do not assume the same cost sharing applies. The EOCs we checked say a mail-order prescription of 34 days or less is not covered, while longer supplies use separate cost-sharing tables. Check the exact form, quantity, and pharmacy first.

How often does the Wellcare formulary change?

Wellcare posts updated drug-list materials during the year and says the formulary can change under Medicare rules. Check the current file before the prescriber sends the request, especially after a new update.

Does Wellcare Medicaid cover GLP-1s?

That depends on your state's preferred drug list, managed-care contract, covered use, and prior authorization rules. The Medicare PDP rules on this page do not apply to Medicaid-only coverage.

Your next three steps

One — identify your exact plan. Value Script, Classic, Medicare Advantage, D-SNP, or Medicaid. It's printed on your card, and it changes every number on this page.

Two — identify which lane you're in. A Part D-covered use goes to the plan. Weight management alone may go to the Medicare GLP-1 Bridge. Getting this wrong costs days or weeks.

Three — verify before your prescriber sends anything. Check the current drug list for your exact plan, confirm the restriction, and know which processor should receive the request.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.

→ Find My GLP-1 Path

• What it asks: your state, insurance situation, medication preference, budget, and support needs
• What you get: a personalized shortlist of GLP-1 treatment paths matched to your situation, with verified pricing and the right questions to ask
• Cost: free · about 60 seconds · no signup

Related guides

• Does Wellcare cover Wegovy?
• What GLP-1 does Humana cover?
• Medicare GLP-1 Bridge tracker
• Medicare GLP-1 Bridge: Part D coverage-gap guide
• GLP-1 formulary tiers explained
• How to request a formulary exception

Primary sources

• Wellcare Value Script 2026 formulary search, HPMS ID 26195
• Wellcare Classic 2026 formulary search, HPMS ID 26191
• Wellcare Value Script 2026 Evidence of Coverage — California, contract S4802
• Wellcare Classic 2026 Evidence of Coverage — California, contract S4802
• Wellcare Value Script 2026 Evidence of Coverage — New York, contract S4802
• Wellcare Classic 2026 Evidence of Coverage — New York, contract S4802
• Wellcare Value Script 2026 GLP-1 prior-authorization criteria
• Wellcare Classic 2026 GLP-1 prior-authorization criteria
• Wellcare 2026 formulary changes
• Wellcare 2026 Alternative Covered Drugs — source for the Bydureon BCise discontinued notation
• Wellcare Medicare GLP-1 Bridge provider bulletin, July 9, 2026
• Medicare.gov: weight-loss drugs and the Medicare GLP-1 Bridge
• CMS: Medicare GLP-1 Bridge information for providers
• Medicare.gov: 2026 Part D costs
• FDA: Rybelsus and Ozempic tablets prescribing information
• FDA: Wegovy prescribing information
• FDA: Zepbound prescribing information
• FDA: Compounding and FDA — Questions and Answers
• Sesame: Medicare weight-management service
• Ro: weight-loss program pricing
• Ro: weight-loss program and insurance

This page is general information, not medical advice, a coverage decision, or a guarantee of approval. The medications named here carry important warnings and situations in which they should not be used. Read the current FDA Medication Guide and discuss your full medical history with your prescriber before starting, stopping, or changing treatment. Coverage details can change during the year — verify against your exact plan's current drug list. The RX Index is not affiliated with Wellcare, Centene, CMS, Medicare, Novo Nordisk, Eli Lilly, Ro, or Sesame.